Filter
5874
Filtered Results: 5874
Text search:
disease
therapy
Featured
Recommendations
551
New Publications
1461
Language
Document type
No document type
3515
Studies & Reports
865
Guidelines
819
Manuals
266
Strategic & Response Plan
142
Fact sheets
109
Training Material
70
Situation Updates
31
Infographics
21
Resource Platforms
14
Brochures
12
Online Courses
7
Dashboards/Maps
1
App
1
Videos
1
Countries / Regions
India
329
Global
213
Kenya
164
South Africa
149
Ethiopia
120
Uganda
116
Nigeria
111
Nepal
107
Western and Central Europe
107
Tanzania
98
Zambia
93
Sierra Leone
91
Malawi
90
Liberia
77
Rwanda
76
Africa
76
Latin America and the Carribbean
70
Bangladesh
62
Ghana
61
Ukraine
60
Eastern Europe
59
Myanmar / Burma
54
Russia
53
Namibia
50
Indonesia
50
Zimbabwe
46
Philippines
45
Asia
44
Lesotho
40
Congo, Democratic Republic of
35
Syria
34
Cambodia
32
Germany
31
South–East Asia Region
30
Senegal
28
Mozambique
28
Brazil
26
Haiti
24
Botswana
24
South Sudan
24
West and Central Africa
21
East and Southern Africa
21
Eswatini/ Swaziland
21
Cameroon
17
Burkina Faso
16
Middle East and North Africa
16
Guinea
15
Colombia
14
Yemen
14
Albania
13
Eastern Europe and Central Asia
13
Paraguay
13
Pakistan
13
Tajikistan
12
Venezuela
11
Afghanistan
10
USA
10
Peru
9
Sudan
9
Angola
9
Benin
8
Iraq
8
Madagascar
8
Thailand
7
Armenia
7
Western Pacific Region
7
Bolivia
7
Argentina
7
Vietnam
7
Moldova
7
Georgia
7
Somalia
7
North Macedonia
6
China
6
North America
6
Southern Africa
6
Central African Republic
6
Ecuador
6
Iran
5
Kyrgyzstan
5
Jordan
5
Spain
5
Lebanon
5
Sri Lanka
5
Bhutan
5
Chile
4
Laos
4
Guinea-Bissau
4
Saudi Arabia
4
United Kingdom
4
Poland
4
Mali
4
Timor Leste/ East Timor
3
Turkey
3
Kazakhstan
3
Canada
3
Hungary
3
Jamaica
3
Papua New Guinea
3
Egypt
3
Romania
3
Chad
3
Switzerland
2
Serbia
2
Fiji
2
Estonia
2
Uzbekistan
2
Qatar
2
Bulgaria
2
Gabon
2
France
2
Mauritius
2
Slovakia
2
Libya
2
North Korea
1
Mexico
1
Gambia
1
Togo
1
Singapore
1
Niger
1
Burundi
1
Malaysia
1
Austria
1
Morocco
1
Mongolia
1
Lithuania
1
Ireland
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Portugal
1
Belarus
1
Latvia
1
Côte d’Ivoire / Ivory Coast
1
Djibouti
1
Greece
1
Palestine
1
Authors & Publishers
Publication Years
Category
Countries
2197
Clinical Guidelines
594
Public Health
333
Women & Child Health
247
Key Resources
163
Capacity Building
83
Pharmacy & Technologies
63
Annual Report MEDBOX
2
Toolboxes
HIV
701
TB
510
Mental Health
494
COVID-19
344
AMR
243
NTDs
225
NCDs
178
Caregiver
152
Pharmacy
144
Disability
143
Ebola & Marburg
112
Rapid Response
107
Conflict
88
Refugee
69
Planetary Health
53
Global Health Education
45
Cholera
38
Natural Hazards
37
Health Financing Toolbox
35
Polio
27
Specific Hazards
22
Zika
18
Social Ethics
12
Malaria
8
South Sudan
1
Ivermectin is an antiparasitic drug approved for the treatment of parasitic infections, including strongyloidiasis and onchocerciasis in humans. There is a reported increase in the use of ivermectin for the prevention and treatment of COVID-19 by the public in African Union Member States.
Currently...
Covid-19 Test to Treat Guidelines
recommended
n response to the outbreak, the Africa Centres for Disease Control and Prevention (Africa CDC) has been supporting African Union Member States in responding to the COVID-19 pandemic through a variety of interventions such as non-pharmaceutical interventions, quarantine, testing, isolation, contact t...
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
Guidelines for Therapy and Management of Hypertension in Cardiovascular Disease in Indonesia
Chronic obstructive pulmonary disease (COPD) is a complex disease that requires differential diagnosis and proper classification to identify appropriate therapy. Nonpharmacologic therapy and preventative measures should be utilized to prevent worsening of disease, symptoms, and complications. The Gl...
Clinical Practice Guidelines and Clinical Pathway for Therapy and Management of Heart Disease and Blood Vessels in Indonesia
The document lists the components of various cholera kits designed for managing cholera outbreaks. It includes items for rehydration therapy (e.g., oral rehydration salts and IV fluids), medications, sanitation supplies, diagnostic tools, and logistical materials such as cholera beds and water purif...
The document provides comprehensive guidelines on cholera outbreak management, including prevention, diagnosis, and treatment. It emphasizes rapid response measures, the importance of rehydration therapy (oral and intravenous), and public health interventions such as water sanitation, hygiene promot...
The document outlines comprehensive guidelines for managing cholera outbreaks in South Africa, focusing on prevention, diagnosis, treatment, and public health measures. It emphasizes the importance of rehydration therapy, sanitation, clean water access, and community involvement to control the sprea...
Over 90% of the morbidity and mortality related to chronic obstructive pulmonary disease (COPD) and asthma occurs in low-income and middle-income countries (LMICs) due to well documented factors including decreased access to screening, trained health professionals, and therapies for disease manageme...
Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society of Cardiology Guidelines for the t...
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma...
Severe and difficult asthma in a low- and middle-income country (LMIC) can relate to lack of availability of basic medications; potentially reversible factors such as poor adherence or comorbidities such as obesity inhibiting a good response to treatment; and (rarely) true severe, therapy-resistant ...
The document provides comprehensive guidance for people with COPD, covering treatment and medication management, oxygen therapy, mucus control, exercise, smoking cessation, nutrition, associated conditions, and strategies to prevent exacerbations. It emphasizes patient education, self-management, an...
The document provides practical guidance for individuals with COPD, covering topics such as medication management, oxygen therapy, mucus control, physical exercise, smoking cessation, nutrition, associated conditions, and how to prevent and manage exacerbations. It emphasizes the importance of patie...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
Existing data on chronic obstructive pulmonary disease (COPD) prevalence are irregularly distributed around the world, and in many geographic regions data are scarce or even nonexistent. This fact hinders the implementation of adequate preventive and therapeutic interventions to reduce the high burd...
Methicillin-resistant Staphylococcus aureus(MRSA) strainsor multidrug-resistant S.aureus, initially described in 1960s,emerged in the last decade as a cause of nosocomial infections responsible for rapidly progressive, potential fatal diseases including life-threatening pneumonia, necrotizing fascii...
Preventing tuberculosis infection from progressing to tuberculosis disease is a crucial component of the goal to eliminate tuberculosis. When deciding on the use of tuberculosis preventive therapy among household contacts, policy makers regularly ask questions, such as whether tuberculosis preventiv...
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are...
